EcoDrugPlus

Ribosomal Protein L32

Ensembl ID : ENSBMUG00000010768
Gene Symbol: RPL32
3 Cross references
231 Possible Orthologues:

Ribosomal Protein L35

Ensembl ID : ENSBMUG00000020431
Gene Symbol: RPL35
3 Cross references
230 Possible Orthologues:

Ribosomal Protein L35a

Ensembl ID : ENSBMUG00000025265
Gene Symbol: RPL35A
2 Cross references
217 Possible Orthologues:

Ribosomal Protein L37

Ensembl ID : ENSBMUG00000026237
Gene Symbol: RPL37
3 Cross references
164 Possible Orthologues:

Ribosomal Protein L37a

Ensembl ID : ENSBMUG00000025782
Gene Symbol: RPL37A
3 Cross references
108 Possible Orthologues:

Ribosomal Protein L38

Ensembl ID : ENSBMUG00000025717
Gene Symbol: RPL38
3 Cross references
243 Possible Orthologues:

Ribosomal Protein L4

Ensembl ID : ENSBMUG00000005950
Gene Symbol: RPL4
2 Cross references
278 Possible Orthologues:

Ribosomal Protein L6

Ensembl ID : ENSBMUG00000007384
Gene Symbol: RPL6
2 Cross references
395 Possible Orthologues:

Ribosomal Protein L7

Ensembl ID : ENSBMUG00000010227
Gene Symbol: RPL7
2 Cross references
296 Possible Orthologues:

Ribosomal Protein S13

Ensembl ID : ENSBMUG00000018750
Gene Symbol: RPS13
2 Cross references
296 Possible Orthologues:

Ribosomal Protein S14

Ensembl ID : ENSBMUG00000013063
Gene Symbol: RPS14
2 Cross references
301 Possible Orthologues:

Ribosomal Protein S15

Ensembl ID : ENSBMUG00000003808
Gene Symbol: RPS15
3 Cross references
233 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).